McK6A1

McK6A1 serves as an inhibitor of amyloid-β (Aβ) aggregation, selectively binding to the 16KLVFFA21 fragment of Aβ42, leading to the formation of an extended β-sheet structure and preventing the formation of Aβ42 oligomers. This compound is valuable for research into Alzheimer's disease and other amyloid-related disorders.

C[C@H]([C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCC[C@@H](C(=O)NNC(=O)C2=C(C=CC(=C2)NC(=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)NCCC[C@@H](C(=O)N1)N)CC3=CC=C(C=C3)O)CCCCN)OC)N)CCCCN)CC4=CC=C(C=C4)O)CC5=CNC6=CC=CC=C65)CC(C)C)O